Transcription of Methicillin-Resistant Staphylococcus aureus
{{id}} {{{paragraph}}}
Methicillin-Resistant Staphylococcus aureus (MRSA) InfectionsActivity C: ELC prevention CollaborativesDraft 1/19/10 ----Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Jernigan, MD, MS Alex Kallen, MD, MPHD ivision of Healthcare Quality PromotionCenters for Disease Control and PreventionOutline Background Impact HHS prevention Targets Pathogenesis Epidemiology prevention Strategies Core Supplemental Measurement Process Outcome Tools for Implementation/Resources/ReferencesBackg round: Impact Staphylococcus aureusis a common cause of healthcare-associated infections Second most common overall cause of healthcare-associated infections reported to the National Healthcare Safety Network (NHSN) Coagulase-negative staphylococci (15%), S. aureus (14%) Most common cause of surgical site infections( 30%) and ventilator associated pneumonia (24%) methicillin -resistance in S.
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives Draft – 1/19/10 ---- Disclaimer: The findings and conclusions in this presentation are those of the authors
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Prevention of Multi-Drug Resistant Organisms, Prevention of Multi-Drug Resistant Organisms MDRO, PREVENTION, MDRO Prevention, MDRO: Prevention in 7 Steps, Infection Prevention and Control in Dialysis, INFECTION PREVENTION AND CONTROL IN, INTER-FACILITY INFECTION CONTROL TRANSFER, Inter-facility Infection Control, HAI for BOT 02-11-08, Management of Carbapenem-Resistant Enterobacteriaceae (CRE) in, National Quality Forum, Risk Assessment Practice, Risk assessment practice sessions – long term